EssilorLuxottica S. A. - Asset Resilience Ratio
EssilorLuxottica S. A. (EL) has an Asset Resilience Ratio of 5.55% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read EssilorLuxottica S. A. (EL) financial obligations for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2001–2024)
This chart shows how EssilorLuxottica S. A.'s Asset Resilience Ratio has changed over time. See net assets of EssilorLuxottica S. A. for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down EssilorLuxottica S. A.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of EssilorLuxottica S. A..
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €3.54 Billion | 5.55% |
| Short-term Investments | €0.00 | 0% |
| Total Liquid Assets | €3.54 Billion | 5.55% |
Asset Resilience Insights
- Limited Liquidity: EssilorLuxottica S. A. maintains only 5.55% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
EssilorLuxottica S. A. Industry Peers by Asset Resilience Ratio
Compare EssilorLuxottica S. A.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
iRay Technology Co Ltd
SHG:688301 |
Medical Instruments & Supplies | 0.68% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 51.82% |
|
Jiangsu Nanfang Medical
SHG:603880 |
Medical Instruments & Supplies | 2.27% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 4.42% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 6.36% |
|
Austco Healthcare Ltd
AU:AHC |
Medical Instruments & Supplies | 15.90% |
|
Trajan Group Holdings Ltd
AU:TRJ |
Medical Instruments & Supplies | 0.23% |
|
Osteopore Ltd
AU:OSX |
Medical Instruments & Supplies | 43.09% |
Annual Asset Resilience Ratio for EssilorLuxottica S. A. (2001–2024)
The table below shows the annual Asset Resilience Ratio data for EssilorLuxottica S. A..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.58% | €375.00 Million ≈ $438.41 Million |
€64.26 Billion ≈ $75.13 Billion |
-0.90pp |
| 2023-12-31 | 1.48% | €896.00 Million ≈ $1.05 Billion |
€60.52 Billion ≈ $70.76 Billion |
-2.14pp |
| 2022-12-31 | 3.62% | €2.19 Billion ≈ $2.56 Billion |
€60.56 Billion ≈ $70.80 Billion |
-4.86pp |
| 2021-12-31 | 8.48% | €5.04 Billion ≈ $5.89 Billion |
€59.41 Billion ≈ $69.46 Billion |
-8.23pp |
| 2020-12-31 | 16.71% | €8.74 Billion ≈ $10.22 Billion |
€52.32 Billion ≈ $61.17 Billion |
+10.09pp |
| 2019-12-31 | 6.62% | €3.48 Billion ≈ $4.07 Billion |
€52.58 Billion ≈ $61.48 Billion |
+5.60pp |
| 2018-12-31 | 1.02% | €496.00 Million ≈ $579.88 Million |
€48.40 Billion ≈ $56.58 Billion |
-3.07pp |
| 2017-12-31 | 4.09% | €412.00 Million ≈ $481.67 Million |
€10.06 Billion ≈ $11.77 Billion |
+3.75pp |
| 2016-12-31 | 0.34% | €45.00 Million ≈ $52.61 Million |
€13.16 Billion ≈ $15.39 Billion |
-0.19pp |
| 2015-12-31 | 0.53% | €64.00 Million ≈ $74.82 Million |
€11.97 Billion ≈ $14.00 Billion |
+0.14pp |
| 2014-12-31 | 0.40% | €43.00 Million ≈ $50.27 Million |
€10.79 Billion ≈ $12.61 Billion |
+0.33pp |
| 2013-12-31 | 0.07% | €5.00 Million ≈ $5.85 Million |
€7.58 Billion ≈ $8.86 Billion |
-0.02pp |
| 2012-12-31 | 0.08% | €5.78 Million ≈ $6.76 Million |
€6.91 Billion ≈ $8.08 Billion |
-0.28pp |
| 2011-12-31 | 0.37% | €22.54 Million ≈ $26.35 Million |
€6.16 Billion ≈ $7.20 Billion |
-0.15pp |
| 2010-12-31 | 0.52% | €26.99 Million ≈ $31.56 Million |
€5.21 Billion ≈ $6.09 Billion |
-1.27pp |
| 2009-12-31 | 1.79% | €74.45 Million ≈ $87.04 Million |
€4.17 Billion ≈ $4.87 Billion |
-0.27pp |
| 2008-12-31 | 2.05% | €83.53 Million ≈ $97.66 Million |
€4.07 Billion ≈ $4.75 Billion |
+0.23pp |
| 2007-12-31 | 1.82% | €63.96 Million ≈ $74.77 Million |
€3.51 Billion ≈ $4.11 Billion |
-0.69pp |
| 2006-12-31 | 2.51% | €78.32 Million ≈ $91.57 Million |
€3.12 Billion ≈ $3.65 Billion |
-15.70pp |
| 2005-12-31 | 18.21% | €551.07 Million ≈ $644.26 Million |
€3.03 Billion ≈ $3.54 Billion |
-3.95pp |
| 2004-12-31 | 22.16% | €572.65 Million ≈ $669.49 Million |
€2.58 Billion ≈ $3.02 Billion |
+1.46pp |
| 2003-12-31 | 20.70% | €516.62 Million ≈ $603.99 Million |
€2.50 Billion ≈ $2.92 Billion |
+11.92pp |
| 2002-12-31 | 8.78% | €189.48 Million ≈ $221.53 Million |
€2.16 Billion ≈ $2.52 Billion |
+7.75pp |
| 2001-12-31 | 1.03% | €22.13 Million ≈ $25.87 Million |
€2.15 Billion ≈ $2.51 Billion |
-- |
About EssilorLuxottica S. A.
EssilorLuxottica Société anonyme designs, manufactures, and distributes ophthalmic lenses, frames, and sunglasses in North America, the Middle East, Africa, Europe, Latin America, and the Asia-Pacific. It offers lens, eyewear, contact lenses, reading glasses under the Essilor, Varilux, Crizal, Eyezen, Stellest, Xperio, Transitions, Ray-Ban, Oakley, Barberini, KODAK Lens, Nikon, Shamir, eyexpert, … Read more